Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent Bruton’s tyrosine kinase inhibitors
Mengzhen Lai(Nanchang University), Jian Ding(Center for Translational Molecular Medicine)
Cited by 6
Related Papers
S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton
|PLoS ONE|2009|55
<i>Grateloupia longifolia</i> polysaccharide inhibits angiogenesis by downregulating tissue factor expression in HMEC‐1 endothelial cells
|British Journal of Pharmacology|2006|50
c-Jun Protects Hypoxia-Inducible Factor-1α from Degradation via Its Oxygen-Dependent Degradation Domain in a Nontranscriptional Manner
|Cancer Research|2009|49
α2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells
|Acta Pharmacologica Sinica|2009|29
C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis
|Acta Pharmacologica Sinica|2018|29